Friday, May 07, 2021 | Last Update : 05:14 PM IST

  Science   21 Apr 2021  COVAXIN effective against multiple variants of SARS-COV-2, double mutant strain: ICMR

COVAXIN effective against multiple variants of SARS-COV-2, double mutant strain: ICMR

ANI
Published : Apr 21, 2021, 1:47 pm IST
Updated : Apr 21, 2021, 1:47 pm IST

This development comes amid the second wave of the COVID-19 pandemic being witnessed across the country

 View of a vial of India's COVAXIN vaccine against COVID-19. (AFP)
  View of a vial of India's COVAXIN vaccine against COVID-19. (AFP)

New Delhi: Indigenously-developed Covid-19 vaccine Covaxin, made by Bharat Biotech, neutralises multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well, the Indian Council of Medical Research (ICMR) said on Wednesday.

The ICMR also informed that the Indian vaccine effectively neutralises the double mutant strain as well, which is being reported in many parts of the country.
"ICMR study shows #COVAXIN neutralises against multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well," the ICMR tweeted.

 

This development comes amid the second wave of the COVID-19 pandemic being witnessed across the country. As per the union health ministry, India on Wednesday crossed a landmark with more than 13 crore people administered with doses of COVID-19 vaccines.

More than 29 Lakh vaccine doses were administered in the last 24 hours.
"Cumulatively, 13,01,19,310 vaccine doses have been administered through 19,01,413 sessions, as per the provisional report till 7 am today," the health ministry said.

Tags: covaxin effectiveness, bharat biotech, covid mutants, covid variants, double mutant strain